LOS ANGELES, CA--(Marketwire - January 24, 2008) - Clearant, Inc. (OTCBB: CLRA) (“Clearant,” “the Company), owner of the Clearant Process®, designed to substantially reduce all types of pathogens in biological products including HIV, today announced it has appointed prominent surgeon Philip A. Davidson, MD to the positions of Chief Medical Officer and Chairman of the Company’s Scientific Advisory Board.
